Loan & DebtApr 22, 2026, 07:46 AM
TuHURA Biosciences Secures $50M Revolving Credit Facility
AI Summary
TuHURA Biosciences, Inc. entered into a $50 million revolving credit facility with Parkview Holdings One LLC, an affiliate of its largest stockholder. The facility, maturing in April 2031, will fund general corporate purposes, including ongoing clinical trials and development programs. Borrowings will bear interest at 12% per annum and are secured by substantially all company assets. This funding is expected to provide sufficient capital into the first half of 2027, contingent on stockholder approval for Loan Fee Shares.
Key Highlights
- Secured $50 million revolving credit facility.
- Matures on April 21, 2031.
- Interest rate of 12% per annum.
- Monthly draws limited to $1.7 million or budgeted expense.
- Expected to fund operations into H1 2027.
Price Impact
More from HURA